NCT05726630Systemic sclerosis (SSc)DivozilimabDIVSScPBOmycophenolate mofetilMMF
…ole of B-cells in the pathogenesis. The aim of LIBERIUS study ( NCT05726630) was to evaluate the efficacy and safety of Divozilimab (DIV), …
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT05726630 ×
NCT05726630
This institution is selected. Its supporting articles are shown below.